What would you decide if 311 million lives depended on it?
What is the FDA doing to streamline regulation and speed innovations to market? Larry Brilliant of the Skoll Global Threats Fund interviews Peggy Hamburg, Commissioner of the FDA.
What is the FDA doing to streamline regulation and speed innovations to market? Larry Brilliant of the Skoll Global Threats Fund interviews Peggy Hamburg, Commissioner of the FDA.
Alzheimer’s may strike 100 million people by 2050. Gregory Petsko, Chair of the Department of Biochemistry at Brandeis University, asks: We know our population is aging. What can …
Gregory Petsko, Chair of the Department of Biochemistry at Brandeis University, answers questions about the coming epidemic of neurological illnesses due to our aging population.
Not all microbes are pathogens. As Jonathan Eisen of the University of California of Davis points out, the health of our microbiome is vital to protecting us from …
Jonathan Eisen of the University of California of Davis answers questions about the human ecosystem, which includes a microbial community that operates as a virtual organ.
Networks guru and author Albert-László Barabási says diseases are the results of system breakdowns within the body, and mapping intracellular protein networks will help us discover cures.
Some two-thirds of cancer are caused by lifestyle choices, says Otis Brawley, chief medical offer of the American Cancer Society. But routine screening, which causes over-diagnosing, is not …
Otis Brawley, Chief Medical Officer of the American Cancer Society, answers questions about cancer overtreatment and how lifestyle choices may cause cancer – even decades later.
Author Albert-László Barabási answers questions on how mapping cellular protein reactions can help us to discover how diseases work.
Triola, of the New York University School of Medicine, and Qualter of BioDigital systems answer audience questions about their BioDigital human 3D virtual anatomy model.